| Literature DB >> 11221875 |
Y I Son1, R M Dallal, R B Mailliard, S Egawa, Z L Jonak, M T Lotze.
Abstract
We investigated the in vitro effects of combining interleukin-18 (IL-18) and IL-2 on human lymphocytes. The combined use of these two cytokines synergistically enhanced the proliferation, cytolytic activity, and interferon-gamma production of peripheral blood mononuclear cells. Phenotypic analysis revealed a preferential expansion of CD56+CD3- cells and an up-regulation of IL-2 receptor-alpha expression on natural killer cells. Isolated natural killer cells showed a substantial increase in proliferation and cytotoxicity compared with CD4+ and CD8+ T cells. The combined use of IL-18 and IL-2 should be considered a viable strategy to induce an antitumor response in vivo.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11221875
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701